Biogen Says Austria And Germany To Become The First Markets In The European Union To Launch Leqembi (Lecanemab)
Aug 25 (Reuters) - Biogen Inc BIIB.O:
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.